H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huakang Biomedical Holdings Co Ltd
Revenue Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Revenue
ÂĄ24.6m
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Revenue
HK$181.8m
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
K
Kelfred Holdings Ltd
HKEX:1134
Revenue
HK$393.3m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Revenue
HK$1.2B
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
-2%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Revenue
$153.9m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Revenue?
Revenue
24.6m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Revenue amounts to 24.6m CNY.

What is Huakang Biomedical Holdings Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
-3%

Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Huakang Biomedical Holdings Co Ltd have been 4% over the past three years , -3% over the past five years .

Back to Top